Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure

被引：0
作者：
David Nathanson
Mats Frick
Bengt Ullman
Thomas Nyström
机构：
[1] Karolinska Institutet,Department of Clinical Science and Education
[2] Södersjukhuset,Department of Endocrinology and Diabetology
[3] Södersjukhuset,Department of Cardiology
来源：
Diabetology & Metabolic Syndrome | / 8卷
关键词：
Atrial natriuretic peptide; Exenatide; GLP-1; Heart failure; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 154 条
  • [51] Dahly A(undefined)undefined undefined undefined undefined-undefined
  • [52] Ditter K(undefined)undefined undefined undefined undefined-undefined
  • [53] Mistry M(undefined)undefined undefined undefined undefined-undefined
  • [54] Kim M(undefined)undefined undefined undefined undefined-undefined
  • [55] Platt MJ(undefined)undefined undefined undefined undefined-undefined
  • [56] Shibasaki T(undefined)undefined undefined undefined undefined-undefined
  • [57] Quaggin SE(undefined)undefined undefined undefined undefined-undefined
  • [58] Backx PH(undefined)undefined undefined undefined undefined-undefined
  • [59] Seino S(undefined)undefined undefined undefined undefined-undefined
  • [60] Ussher JR(undefined)undefined undefined undefined undefined-undefined
12345678910